QLi5 Therapeutics GmbH
PrivateLast Round
Corporate Funding
Dec 18, 2025
Total Funding Raised
$17.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QLi5 Therapeutics GmbH is a biotechnology company that develops a next-generation platform of non-covalent proteasome inhibitors for the treatment of cancer, inflammatory, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QLi5 Therapeutics GmbH Comparables
Compare QLi5 Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iProtics | 82% | |
| IpiNovyx Bio | 79% | |
| Johnson & Johnson | 73% |
QLi5 Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 18, 2025 | ||||
| Series A | Sep 7, 2022 |
QLi5 Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series A |
| KTB Investment Group | Series A |
| Atinum Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$7.3M round led by Qurient Co. Ltd
QLi5 Therapeutics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about QLi5 Therapeutics GmbH's valuation, stock price, and market status.
Is QLi5 Therapeutics GmbH a public or private company?
QLi5 Therapeutics GmbH is a private company.
What is the current stock price of QLi5 Therapeutics GmbH?
QLi5 Therapeutics GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is QLi5 Therapeutics GmbH worth (valuation)?
Valuation information for QLi5 Therapeutics GmbH is not publicly available.
Can I buy QLi5 Therapeutics GmbH stock?
QLi5 Therapeutics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was QLi5 Therapeutics GmbH's last funding round?
QLi5 Therapeutics GmbH's most recent funding round was Corporate Funding on December 18, 2025.
Who are the main investors in QLi5 Therapeutics GmbH?
Key investors in QLi5 Therapeutics GmbH include SV Investment, KTB Investment Group, Atinum Investment.
Will QLi5 Therapeutics GmbH IPO soon?
No public IPO plans have been announced for QLi5 Therapeutics GmbH.
How can I track QLi5 Therapeutics GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QLi5 Therapeutics GmbH's secondary market activity and sign up for updates.